Cumberland Pharmaceuticals (CPIX) Change in Intangibles (2010 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Change in Intangibles came in at $19155.0 in Q1 2026, up 5.25% year-on-year from $18199.0 in Q1 2025, and down 56.31% quarter-over-quarter from $43842.0 in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Change in Intangibles (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Change in Intangibles across 17 years of filings, most recently posting $19155.0 for Q1 2026.
- Change in Intangibles for Q1 2026 came in at $19155.0, up 5.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $85358.0 (down 25.7% YoY), and the FY2025 annual result was $84402.0, down 25.47% from the prior year.
- Change in Intangibles came in at $19155.0 for Q1 2026 at Cumberland Pharmaceuticals, down from $43842.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $1.8 million in Q4 2022 to a low of $8449.0 in Q3 2025.
- The 5-year median for Change in Intangibles is $32536.0 (2024), against an average of $138838.5.
- Across the five-year window, Change in Intangibles jumped 2451.73% in 2022 and slumped 97.88% in 2023, its largest moves.
- Cumberland Pharmaceuticals' Change in Intangibles stood at $1.8 million in 2022, then plunged by 97.88% to $38044.0 in 2023, then plunged by 35.53% to $24526.0 in 2024, then surged by 78.76% to $43842.0 in 2025, then sank by 56.31% to $19155.0 in 2026.
- The last three Change in Intangibles figures came in at $19155.0 (Q1 2026), $43842.0 (Q4 2025), and $8449.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Cumberland Pharmaceuticals | 84.67 Mn | 73.33 Mn | 7.20 Mn | 19,155.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,155.00 |
| Mar 31, 2026 | 19,155.00 |
| Dec 31, 2025 | 43,842.00 |
| Dec 31, 2025 | 43,842.00 |
| Sep 30, 2025 | 8,449.00 |
| Sep 30, 2025 | 8,449.00 |
| Jun 30, 2025 | 13,912.00 |
| Jun 30, 2025 | 13,912.00 |
| Mar 31, 2025 | 18,199.00 |
| Mar 31, 2025 | 18,199.00 |
| Dec 31, 2024 | 24,526.00 |
| Dec 31, 2024 | 24,526.00 |
| Sep 30, 2024 | 32,536.00 |
| Sep 30, 2024 | 32,536.00 |
| Jun 30, 2024 | 39,626.00 |
| Jun 30, 2024 | 39,626.00 |
| Mar 31, 2024 | 16,565.00 |
| Mar 31, 2024 | 16,565.00 |
| Dec 31, 2023 | 38,044.00 |
| Dec 31, 2023 | 38,044.00 |